tiprankstipranks
Trending News
More News >
Molina Healthcare (MOH)
NYSE:MOH
US Market
Advertisement

Molina Healthcare (MOH) Stock Forecast & Price Target

Compare
936 Followers
See the Price Targets and Ratings of:

MOH Analyst Ratings

Hold
13Ratings
Hold
4 Buy
8 Hold
1 Sell
Based on 13 analysts giving stock ratings to
Molina
Healthcare
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

MOH Stock 12 Month Forecast

Average Price Target

$245.00
▲(54.85%Upside)
Based on 13 Wall Street analysts offering 12 month price targets for Molina Healthcare in the last 3 months. The average price target is $245.00 with a high forecast of $330.00 and a low forecast of $179.00. The average price target represents a 54.85% change from the last price of $158.22.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"178":"$178","221":"$221","264":"$264","307":"$307","350":"$350"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":330,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$330.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":245,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$245.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":179,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$179.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[178,221,264,307,350],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2024","6":"Jan<br/>2025","9":"Apr<br/>2025","12":"Jul<br/>2025","25":"Jul<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,306.29,308.11384615384617,309.9376923076923,311.76153846153846,313.5853846153846,315.40923076923076,317.2330769230769,319.0569230769231,320.88076923076926,322.7046153846154,324.52846153846156,326.3523076923077,328.17615384615385,{"y":330,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,306.29,301.5753846153846,296.8607692307692,292.1461538461539,287.4315384615385,282.7169230769231,278.0023076923077,273.28769230769234,268.57307692307694,263.85846153846154,259.14384615384614,254.42923076923077,249.7146153846154,{"y":245,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,306.29,296.4984615384616,286.7069230769231,276.91538461538465,267.12384615384616,257.3323076923077,247.54076923076923,237.7492307692308,227.9576923076923,218.16615384615386,208.37461538461537,198.58307692307693,188.79153846153847,{"y":179,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":292.16,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":346.19,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":349.79,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":341.91,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":326.75,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":301.87,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":291.05,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":310.41,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":301.12,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":327.71,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":313.04,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":297.35,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":306.29,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$330.00Average Price Target$245.00Lowest Price Target$179.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on MOH
TipRanks AITipRanks
Not Ranked
TipRanks
$202
Buy
27.67%
Upside
Reiterated
07/19/25
Molina Healthcare's strong financial performance and strategic growth initiatives are the primary drivers of its stock score. However, bearish technical indicators and challenges mentioned in the earnings call, such as the loss of the Virginia contract, weigh down the overall score. Despite valuation suggesting undervaluation, the lack of dividend yield and technical downtrend pose risks.
Truist Financial Analyst forecast on MOH
David S MacdonaldTruist Financial
Truist Financial
Buy
Reiterated
07/24/25
Truist Financial Remains a Buy on Molina Healthcare (MOH)
Cantor Fitzgerald Analyst forecast on MOH
Sarah JamesCantor Fitzgerald
Cantor Fitzgerald
$312$210
Hold
32.73%
Upside
Downgraded
07/24/25
Molina Healthcare (MOH) Gets a Buy from Cantor FitzgeraldCantor Fitzgerald analyst Sarah Jameas reiterated an Overweight rating and $312.00 price target on Molina Healthcare (NYSE: MOH).
Bank of America Securities Analyst forecast on MOH
Kevin FischbeckBank of America Securities
Bank of America Securities
$218$190
Sell
20.09%
Upside
Reiterated
07/24/25
Analysts Have Conflicting Sentiments on These Healthcare Companies: Molina Healthcare (NYSE: MOH), Sarepta Therapeutics (NASDAQ: SRPT) and Roche Holding AG (Other OTC: RHHVF)Reiterate Rating: UNDERPERFORM | PO: 190.00 USD | Price: 190.25 USD; we reiterate our Underperform rating and lower our PO to $190 from $218
TD Cowen
$283
Buy
78.86%
Upside
Reiterated
07/24/25
Analysts Offer Insights on Healthcare Companies: Icon (NASDAQ: ICLR) and Molina Healthcare (NYSE: MOH)
Barclays
$270
Hold
70.65%
Upside
Reiterated
07/24/25
Barclays Sticks to Its Hold Rating for Molina Healthcare (MOH)
Wells Fargo Analyst forecast on MOH
Stephen BaxterWells Fargo
Wells Fargo
$372$216
Buy
36.52%
Upside
Reiterated
07/23/25
Molina Healthcare price target lowered to $216 from $372 at Wells FargoMolina Healthcare price target lowered to $216 from $372 at Wells Fargo
Bernstein Analyst forecast on MOH
Lance WilkesBernstein
Bernstein
$414$284
Buy
79.50%
Upside
Reiterated
07/16/25
Bernstein Reaffirms Their Buy Rating on Molina Healthcare (MOH)
J.P. Morgan Analyst forecast on MOH
John StanselJ.P. Morgan
J.P. Morgan
$333$272
Hold
71.91%
Upside
Reiterated
07/14/25
Molina Healthcare (MOH) Receives a Hold from J.P. Morgan
Mizuho Securities Analyst forecast on MOH
Ann HynesMizuho Securities
Mizuho Securities
$400$330
Buy
108.57%
Upside
Reiterated
07/11/25
Molina Healthcare price target lowered to $330 from $400 at MizuhoMolina Healthcare price target lowered to $330 from $400 at Mizuho
Morgan Stanley Analyst forecast on MOH
Erin WrightMorgan Stanley
Morgan Stanley
$364$266
Hold
68.12%
Upside
Downgraded
07/10/25
Molina Healthcare (MOH) was downgraded to a Hold Rating at Morgan Stanley
Wolfe Research Analyst forecast on MOH
Justin LakeWolfe Research
Wolfe Research
Hold
Reiterated
07/10/25
Wolfe Research Sticks to Their Hold Rating for Molina Healthcare (MOH)
UBS
$325$260
Hold
64.33%
Upside
Reiterated
07/08/25
UBS Sticks to Their Hold Rating for Molina Healthcare (MOH)
Robert W. Baird Analyst forecast on MOH
Michael HaRobert W. Baird
Robert W. Baird
$331$375
Hold
137.01%
Upside
Downgraded
04/14/25
Molina Healthcare downgraded to Neutral from Outperform at BairdMolina Healthcare downgraded to Neutral from Outperform at Baird
Guggenheim Analyst forecast on MOH
Jason CassorlaGuggenheim
Guggenheim
Hold
Initiated
04/08/25
Guggenheim starts Molina Healthcare (MOH) at NeutralGuggenheim analyst Jason Cassorla initiates coverage on Molina Healthcare (NYSE: MOH) with a Neutral rating.
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on MOH
TipRanks AITipRanks
Not Ranked
TipRanks
$202
Buy
27.67%
Upside
Reiterated
07/19/25
Molina Healthcare's strong financial performance and strategic growth initiatives are the primary drivers of its stock score. However, bearish technical indicators and challenges mentioned in the earnings call, such as the loss of the Virginia contract, weigh down the overall score. Despite valuation suggesting undervaluation, the lack of dividend yield and technical downtrend pose risks.
Truist Financial Analyst forecast on MOH
David S MacdonaldTruist Financial
Truist Financial
Buy
Reiterated
07/24/25
Truist Financial Remains a Buy on Molina Healthcare (MOH)
Cantor Fitzgerald Analyst forecast on MOH
Sarah JamesCantor Fitzgerald
Cantor Fitzgerald
$312$210
Hold
32.73%
Upside
Downgraded
07/24/25
Molina Healthcare (MOH) Gets a Buy from Cantor FitzgeraldCantor Fitzgerald analyst Sarah Jameas reiterated an Overweight rating and $312.00 price target on Molina Healthcare (NYSE: MOH).
Bank of America Securities Analyst forecast on MOH
Kevin FischbeckBank of America Securities
Bank of America Securities
$218$190
Sell
20.09%
Upside
Reiterated
07/24/25
Analysts Have Conflicting Sentiments on These Healthcare Companies: Molina Healthcare (NYSE: MOH), Sarepta Therapeutics (NASDAQ: SRPT) and Roche Holding AG (Other OTC: RHHVF)Reiterate Rating: UNDERPERFORM | PO: 190.00 USD | Price: 190.25 USD; we reiterate our Underperform rating and lower our PO to $190 from $218
TD Cowen
$283
Buy
78.86%
Upside
Reiterated
07/24/25
Analysts Offer Insights on Healthcare Companies: Icon (NASDAQ: ICLR) and Molina Healthcare (NYSE: MOH)
Barclays
$270
Hold
70.65%
Upside
Reiterated
07/24/25
Barclays Sticks to Its Hold Rating for Molina Healthcare (MOH)
Wells Fargo Analyst forecast on MOH
Stephen BaxterWells Fargo
Wells Fargo
$372$216
Buy
36.52%
Upside
Reiterated
07/23/25
Molina Healthcare price target lowered to $216 from $372 at Wells FargoMolina Healthcare price target lowered to $216 from $372 at Wells Fargo
Bernstein Analyst forecast on MOH
Lance WilkesBernstein
Bernstein
$414$284
Buy
79.50%
Upside
Reiterated
07/16/25
Bernstein Reaffirms Their Buy Rating on Molina Healthcare (MOH)
J.P. Morgan Analyst forecast on MOH
John StanselJ.P. Morgan
J.P. Morgan
$333$272
Hold
71.91%
Upside
Reiterated
07/14/25
Molina Healthcare (MOH) Receives a Hold from J.P. Morgan
Mizuho Securities Analyst forecast on MOH
Ann HynesMizuho Securities
Mizuho Securities
$400$330
Buy
108.57%
Upside
Reiterated
07/11/25
Molina Healthcare price target lowered to $330 from $400 at MizuhoMolina Healthcare price target lowered to $330 from $400 at Mizuho
Morgan Stanley Analyst forecast on MOH
Erin WrightMorgan Stanley
Morgan Stanley
$364$266
Hold
68.12%
Upside
Downgraded
07/10/25
Molina Healthcare (MOH) was downgraded to a Hold Rating at Morgan Stanley
Wolfe Research Analyst forecast on MOH
Justin LakeWolfe Research
Wolfe Research
Hold
Reiterated
07/10/25
Wolfe Research Sticks to Their Hold Rating for Molina Healthcare (MOH)
UBS
$325$260
Hold
64.33%
Upside
Reiterated
07/08/25
UBS Sticks to Their Hold Rating for Molina Healthcare (MOH)
Robert W. Baird Analyst forecast on MOH
Michael HaRobert W. Baird
Robert W. Baird
$331$375
Hold
137.01%
Upside
Downgraded
04/14/25
Molina Healthcare downgraded to Neutral from Outperform at BairdMolina Healthcare downgraded to Neutral from Outperform at Baird
Guggenheim Analyst forecast on MOH
Jason CassorlaGuggenheim
Guggenheim
Hold
Initiated
04/08/25
Guggenheim starts Molina Healthcare (MOH) at NeutralGuggenheim analyst Jason Cassorla initiates coverage on Molina Healthcare (NYSE: MOH) with a Neutral rating.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Molina Healthcare

1 Month
xxx
Success Rate
10/19 ratings generated profit
53%
Average Return
-0.67%
reiterated a xxx
rating 3 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 52.63% of your transactions generating a profit, with an average return of -0.67% per trade.
3 Months
xxx
Success Rate
17/30 ratings generated profit
57%
Average Return
+2.35%
reiterated a xxx
rating 2 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 56.67% of your transactions generating a profit, with an average return of +2.35% per trade.
1 Year
Sarah JamesCantor Fitzgerald
Success Rate
17/26 ratings generated profit
65%
Average Return
+22.27%
reiterated a buy rating 2 days ago
Copying Sarah James's trades and holding each position for 1 Year would result in 65.38% of your transactions generating a profit, with an average return of +22.27% per trade.
2 Years
xxx
Success Rate
16/30 ratings generated profit
53%
Average Return
+3.24%
reiterated a xxx
rating 2 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 53.33% of your transactions generating a profit, with an average return of +3.24% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

MOH Analyst Recommendation Trends

Rating
Mar 25
Apr 25
May 25
Jun 25
Jul 25
Strong Buy
0
0
0
0
5
Buy
10
16
13
17
18
Hold
5
9
4
6
10
Sell
1
2
1
1
2
Strong Sell
0
0
0
0
0
total
16
27
18
24
35
In the current month, MOH has received 23 Buy Ratings, 10 Hold Ratings, and 2 Sell Ratings. MOH average Analyst price target in the past 3 months is 245.00.
Each month's total comprises the sum of three months' worth of ratings.

MOH Financial Forecast

MOH Earnings Forecast

Next quarter’s earnings estimate for MOH is $5.28 with a range of $3.75 to $6.38. The previous quarter’s EPS was $5.48. MOH beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.13% of the time in the same period. In the last calendar year MOH has Outperformed its overall industry.
Next quarter’s earnings estimate for MOH is $5.28 with a range of $3.75 to $6.38. The previous quarter’s EPS was $5.48. MOH beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.13% of the time in the same period. In the last calendar year MOH has Outperformed its overall industry.

MOH Sales Forecast

Next quarter’s sales forecast for MOH is $10.97B with a range of $10.69B to $11.32B. The previous quarter’s sales results were $11.43B. MOH beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 47.59% of the time in the same period. In the last calendar year MOH has Outperformed its overall industry.
Next quarter’s sales forecast for MOH is $10.97B with a range of $10.69B to $11.32B. The previous quarter’s sales results were $11.43B. MOH beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 47.59% of the time in the same period. In the last calendar year MOH has Outperformed its overall industry.

MOH Stock Forecast FAQ

What is MOH’s average 12-month price target, according to analysts?
Based on analyst ratings, Molina Healthcare’s 12-month average price target is 245.00.
    What is MOH’s upside potential, based on the analysts’ average price target?
    Molina Healthcare has 54.85% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is MOH a Buy, Sell or Hold?
          Molina Healthcare has a consensus rating of Hold which is based on 4 buy ratings, 8 hold ratings and 1 sell ratings.
            What is Molina Healthcare’s price target?
            The average price target for Molina Healthcare is 245.00. This is based on 13 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $330.00 ,the lowest forecast is $179.00. The average price target represents 54.85% Increase from the current price of $158.22.
              What do analysts say about Molina Healthcare?
              Molina Healthcare’s analyst rating consensus is a Hold. This is based on the ratings of 13 Wall Streets Analysts.
                How can I buy shares of MOH?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis